http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014115989-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D455-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2012-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014115989-A |
| titleOfInvention | PURE L-ARGININE SALT TETRACHYDRATE S - (-) - 9-fluoro-6, 7-dihydro-8- (4-hydroxypiperidine-1-yl) -5-methyl-1-oxo-1H, -5h-benzo [i , j] CHINOLYSINE-2-CARBONIC ACID AND METHOD OF ITS PRODUCTION |
| abstract | 1. L-arginine salt tetrahydrate S - (-) - 9-fluoro-6,7-dihydro-8- (4-hydroxypiperidin-1-yl) -5-methyl-1-oxo-1H, -5H-benzo [ i, j] quinolysin-2-carboxylic acid having a purity of at least 99% w / w, as determined by HPLC. 2. L-arginine salt tetrahydrate S - (-) - 9-fluoro-6,7-dihydro-8- (4-hydroxypiperidin-1-yl) -5-methyl-1-oxo-1H, -5H-benzo [i, j] quinolysin-2-carboxylic acid according to claim 1, further comprising less than 0.15% w / w. 9-fluoro-8-hydroxy-5-methyl-6,7-dihydro-1-oxo-1H, 5H-benzo [i, j] quinolizine-2-carboxylic acid, as determined by HPLC. 3. L-arginine salt tetrahydrate S - (-) - 9-fluoro-6,7-dihydro-8- (4-hydroxypiperidin-1-yl) -5-methyl-1-oxo-1H, -5H-benzo [i, j] quinolysin-2-carboxylic acid according to claim 1, further comprising less than 0.15% w / w. 8-fluoro-9- (4-hydroxypiperidin-1-yl) -5-methyl-6,7-dihydro-1-oxo-1H, 5H-benzo [i, j] quinolysin-2-carboxylic acid, as defined with using HPLC. 4. L-arginine salt tetrahydrate S - (-) - 9-fluoro-6,7-dihydro-8- (4-hydroxypiperidin-1-yl) -5-methyl-1-oxo-1H, -5H-benzo [i, j] quinolysin-2-carboxylic acid according to claim 1, further comprising less than 0.15% w / w. 8- (4-hydroxy-1-piperidinyl) -5-methyl-6,7-dihydro-1-oxo-1H, 5H-benzo [i, j] quinolysin-2-carboxylic acid, as determined by HPLC. 5 . L-arginine salt tetrahydrate S - (-) - 9-fluoro-6,7-dihydro-8- (4-hydroxypiperidin-1-yl) -5-methyl-1-oxo-1H, -5H-benzo [i, j] quinolysin-2-carboxylic acid according to claim 1, further comprising less than 0.15% w / w. 8,9-difluoro-5-methyl-6,7-dihydro-1-oxo-1H, 5H-benzo [i, j] quinolysin-2-carboxylic acid, as determined by HPLC. 6. L-arginine salt tetrahydrate S - (-) - 9-fluoro-6,7-dihydro-8- (4-hydroxypiperidin-1-yl) -5-methyl-1-oxo-1H, -5H-benzo [i, j] quinolysin-2-carboxylic acid according to claim 1, further comprising less than 0.5% w / w. R - (+) - 9-� |
| priorityDate | 2011-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.